Cerebrospinal fluid biomarkers, education, brain volume, and future cognition.

BACKGROUND Cross-sectional studies suggest that the cognitive impact of Alzheimer disease pathology varies depending on education and brain size. OBJECTIVE To evaluate the combination of cerebrospinal fluid biomarkers of β-amyloid(42) (Aβ(42)), tau, and phosphorylated tau (ptau(181)) with education and normalized whole-brain volume (nWBV) to predict incident cognitive impairment. DESIGN Longitudinal cohort study. SETTING Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University, St Louis, Missouri. PARTICIPANTS A convenience sample of 197 individuals 50 years and older with normal cognition (Clinical Dementia Rating of 0) at baseline observed for a mean of 3.3 years. MAIN OUTCOME MEASURE Time to Clinical Dementia Rating ≥ 0.5. RESULTS Three-factor interactions among the baseline biomarker values, education, and nWBV were found for Cox proportional hazards regression models testing tau (P = .02) and ptau (P = .008). In those with lower tau values, nWBV (hazard ratio [HR], 0.54; 95% confidence interval [CI], 0.31-0.91; P = .02), but not education, was related to time to cognitive impairment. For participants with higher tau values, education interacted with nWBV to predict incident impairment (P = .01). For individuals with lower ptau values, there was no effect of education or nWBV. Education interacted with nWBV to predict incident cognitive impairment in those with higher ptau values (P = .02). CONCLUSION In individuals with normal cognition and higher levels of cerebrospinal fluid tau and ptau at baseline, time to incident cognitive impairment is moderated by education and brain volume as predicted by the cognitive/brain reserve hypothesis.

[1]  John X. Morris,et al.  Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease , 2011, Neurology.

[2]  J. Morris,et al.  Autobiographical memory task in assessing dementia. , 2010, Archives of neurology.

[3]  M. Weiner,et al.  Cerebrospinal fluid and plasma biomarkers in Alzheimer disease , 2010, Nature Reviews Neurology.

[4]  Yaakov Stern,et al.  Cognitive Reserve: Implications for Assessment and Intervention , 2013, Folia Phoniatrica et Logopaedica.

[5]  J. Morris,et al.  Stability of the Clinical Dementia Rating, 1979-2007. , 2009, Archives of neurology.

[6]  A. Fagan,et al.  Decreased cerebrospinal fluid Aβ42 correlates with brain atrophy in cognitively normal elderly , 2009, Annals of neurology.

[7]  M. Mintun,et al.  Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake. , 2008, Archives of neurology.

[8]  Michael J Valenzuela,et al.  Brain reserve and the prevention of dementia , 2008, Current opinion in psychiatry.

[9]  J. Morris,et al.  Interaction of Neuritic Plaques and Education Predicts Dementia , 2008, Alzheimer disease and associated disorders.

[10]  M. Viitanen,et al.  Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease , 2008, Annals of neurology.

[11]  I. Sokal,et al.  CSF tau/Aβ42 ratio for increased risk of mild cognitive impairment , 2007, Neurology.

[12]  B. Reisberg.  Global measures: utility in defining and measuring treatment response in dementia , 2007, International Psychogeriatrics.

[13]  A. Fagan,et al.  Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. , 2007, Archives of neurology.

[14]  J Philip Miller,et al.  Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI , 2006, Neurology.

[15]  Y. Stern.  Cognitive Reserve and Alzheimer Disease , 2006, Alzheimer disease and associated disorders.

[16]  Gina N. LaRossa,et al.  Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans , 2006, Annals of neurology.

[17]  Karen M. Gosche,et al.  Very Early Detection of Alzheimer Neuropathology and the Role of Brain Reserve in Modifying Its Clinical Expression , 2005, Journal of geriatric psychiatry and neurology.

[18]  D. Bennett,et al.  Education modifies the association of amyloid but not tangles with cognitive function , 2005, Neurology.

[19]  R. Buckner,et al.  Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD , 2005, Neurology.

[20]  Abraham Z. Snyder,et al.  A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume , 2004, NeuroImage.

[21]  W. Markesbery,et al.  Head Circumference, Education and Risk of Dementia: Findings from the Nun Study , 2003, Journal of clinical and experimental neuropsychology.

[22]  J. Schneider,et al.  Education modifies the relation of AD pathology to level of cognitive function in older persons , 2003, Neurology.

[23]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[24]  G. Schellenberg,et al.  Head circumference and incident Alzheimer’s disease , 2001, Neurology.

[25]  Martin Styner,et al.  Parametric estimate of intensity inhomogeneities applied to MRI , 2000, IEEE Transactions on Medical Imaging.

[26]  J. Price,et al.  Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. , 1998, Archives of neurology.

[27]  L. Thal,et al.  Clinical Dementia Rating training and reliability in multicenter studies , 1997, Neurology.

[28]  E. Mori,et al.  Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease. , 1997, The American journal of psychiatry.

[29]  R. Mayeux,et al.  Influence of education and occupation on the incidence of Alzheimer's disease. , 1994, JAMA.

[30]  J. Morris.  The Clinical Dementia Rating (CDR) , 1993, Neurology.

[31]  R. Katzman.,et al.  Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques , 1988, Annals of neurology.

[32]  R. Katzman.,et al.  Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. , 1983, The American journal of psychiatry.

[33]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[34]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[35]  Stephen M. Smith,et al.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.

[36]  D. Gurwitz,et al.  Head circumference and incident Alzheimer's disease: modification by apolipoprotein E. , 2001, Neurology.

[37]  J. Duchek,et al.  Reliability of the Washington University Clinical Dementia Rating. , 1988, Archives of neurology.